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Introduction to  the subject of intra-partum 
electronic monitoring 
Sadly but inevitably, the clinical fruit of all 
scientific research, like the profile of the Roman god 
Janus, presents us with two faces  - one is patient benefit 
while the other is medico-legal vulnerability. As part of 
defensive medicine, there are situations where 
malpractice risk is minimised by actual elimination of 
certain high-risk procedures e.g. in the case of some 
neurosurgical1 operations. Intra-partum electronic fetal 
monitoring (IPEFM) is the commonest obstetric 
procedure in the developed world,2 producing valuable 
information of fetal well being as co-related to maternal 
uterine activity with a scope of guarding fetal well-being 
in labour. It is a prime example of the therapeutic/ legal 
liability duality which haunts modern Medicine.  
The rationale of the use of IPEFM is based on the fact 
that labour is the shortest but most dangerous trip ever 
undertaken by man. Every uterine contraction – 
indispensable for the mechanical process of 
exteriorisation of the fetus – is associated with a 
diminution of blood flow to the feto-placental 
cardiovascular unit. The resulting challenge may not be 
handled well by the unborn infant resulting in the 
complex known as fetal distress (the use of this term is 
being increasingly challenged by the American College 
of Obstetricians and Gynaecologists – on grounds 
considered very debatable in this author’s opinion.  The 
term is still used by the Royal College of Obstetricians 
and Gynaecologists of London. It can still be used –and 
without any apologies). This is especially likely but 
certainly not limited to3 the scenario where the patient 
enters the obstetric arena with an ‘ab initio’ poorly 
functioning placenta.   
 
Short history 
It is instructive to take a short look at the present 
form of IPEFM. Clinically available in the 1960s, 
IIPEFM in the form of Cardiotocography (CTG) quickly 
substituted4 the old fashioned Intermittent Auscultation 
(IA) method of direct fetal stethoscope listening to the 
fetal heart [Normally done at regular intervals by the 
midwife using a Pinard stethoscope (one of many 
types)]. Clinical widespread cardiotocography 
commenced by 1966 when Hammacher developed a 
suitable recording system, which was freely available for 
routine use in 1968.5 Caldeyro-Barcia [Roberto 
Caldeyro-Barcia (26 September 1921 – 2 November 
1996), nominated for a Nobel Prize for his work on 
Feto-Maternal Medicine] was not only a great 
contributor to the discipline through his work on uterine 
physiology and patho-physiology but also coined the 
original nomenclature which he himself found 
unsatisfactory on further evaluation and stopped using 
by the 1970s. By that time, CTG monitoring was used in 
84% of all U.S. births, regardless of whether the primary 
caregiver was a physician or a midwife.6 Intrapartum 
CTG use is now universally entrenched in spite of any 
varying albeit methodology of interpretation (one unit 
may use computerised analysis, another may combine 
with ST analysis of the fetal ECG STAN etc.). Hospitals 
and physicians have billed and been collectively paid 
many millions of dollars for the use of CTGs since its 
universal acceptance in the 1960s.7 IPFM in the form of 
a permanent CTG tracing strip has also proved to be 
manna from Heaven in the hands of lawyers instituting 
action in cases with undesired end result where a child 
suffers hypoxic intrapartum damage.  
 
Clinical and legal equivocity  
In spite of  evidence demonstrating limited neonatal benefit, 
the medico - legal  climate often pressurises obstetricians to integrate 
continuous IPEFM in the form of CTG as  surveillance into their 
care of the pregnant labouring patient,8 even if the various Colleges 
such the American College and the U.K’s Royal College of 
Obstetricians and Gynaecologists have published specific guidelines 
as to when to implement such monitoring. The medico-legal 
aspect of IPEFM itself is rendered extremely complex 
firstly because of the applicability of legal principles to a 
phenomenon which by medico-legal standards  has 
somewhat of the properties of “shifting sands”.  This 
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fascinating aspect cannot be dwelt on in any depth here 
but suffice it to quote here the high observer subjectivity 
of interpretation of CTG tracings. Another reason adding 
to the complexity of IPEFM in the Courtroom is a 
corollary of the “shifting sands” aspect and that is that to 
the plague of subjectivity one must add the scientific 
controversy9 which surrounds the subject. Among these 
we find the already referred to poor inter and intra-
observer reliability,10 high false positive rate of up to 
60%,11 the unquestioned contribution to an increased 
Caesarean Section rate12 as well as its failure to deliver 
the much expected pregnancy outcome improved as 
compared to |IA.12 
 
Diminishing the medico-legal risk 
The scope of this article is to attract clinical 
attention to a few of the innumerable, salient points 
which come into their own once IPEFM enetering the 
legal arena.  
 
The use of correct nomenclature 
Shakespeare’s oft quoted dictum in Romeo and 
Juliet ("a rose by any other name would smell as sweet") 
would not hold much water in the subject at hand. It is 
annoying at best, misleading at worst and open to 
challenge in Court at any stage to refer to a CTG strip 
using the old Caldeyro Barcia classification (such as 
using ‘Type I dips’ or ‘Type II dips.) Sometimes, 
ironically the ante-deluvian term ‘dips’ is actually mish-
mashed with the correct term ‘decelerations’ in the same 
sentence.   These are not airy-fairy changes of 
nomenclature but reflect genuine physiological 
principles which are scientifically challengable in Court. 
Other terms such as ‘beat to beat’ variation rather than 
‘variability’ reflect knowledge pertaining to the older 
CTG machines and though not quite as misleading as 
‘dips’, still render medico-legally vulnerable through 
lack of updated knowledge. While good obstetric 
practice  demands the use of the most recent, 
standardized, quantitative nomenclature to interpret  
intra-partum CTG, to minimise  miscommunication, 
propagate consistent, evidence-based responses to CTG 
patterns, and systematize research terminology13 the 
standards of Court litigation demand no less precision.   
With this mind it is disconcerting to hear the Court 
itself  delivering a scientifically challengeable statement 
(as late as 2009) in Whiston v London Strategic Health 
Authority:    
It is said that if the CTG had still been available the 
court would be able to tell when it was discontinued and 
whether there were Type II dips and, if so, for how long 
(i e whether they were continuous).14 
One wonders at the possible sequelae at a Court of 
Appeal if the very momenclature employed was 
outdated, for  appeals have been  won or lost on much 
weaker technical points. The Court has a firm 
“commitment to mainstream science, so that we could 
avoid inconsistent verdicts in mass tort litigation”.15 
By contrast, it is a veritable pleasure to read the 
clear and scientifically correct exposé in Smith v West 
Yorkshire Health Authority (t/a Leeds Health Authority). 
The Judge speaks of ‘baseline variability’, ‘decelerations 
and correctly refers to the reassurance generally elicited 
by accelerations with uterine contractions or movements. 
In reverse to the fit adult, accelerations of the fetal heart 
rate during the challenge of a maternal uterine 
contraction or a fetal movement, are a reassuring 
indicator of fetal well-being.  
 Baseline variability describes the changes in the 
baseline of the FHR. Such changes occur slowly unless 
there is an acute accident. Accelerations are the 
increases in the FHR and they are a positive and 
reassuring sign if they occur as a response to uterine 
contractions or movements in which case they are seen 
occasionally. They may not occur regularly but they 
should be seen occasionally. Decelerations are 
reductions in the FHR of more than 15 beats per minute 
from the baseline rate, while accelerations are increases 
in the FHR of more than 15 beats per minute.16 
 No serious case can be put forward either by 
plaintiff or defendant unless correct information on 
current nomenclature and guidelines is provided by 
correct expert advice. A good example comes across in 
Brodie McCoy v East Midlands Strategic Health 
Authority, (reference being made in this case to an 
antenatal and not intrapartum CTG tracing) where 
defence was not only well versed with the 1987 FIGO 
Guidelines for CTG interpretation but intelligently and 
justifiably attacked one of its Achilles tendons : 
…reference was made to the 1987 FIGO Guidelines 
for interpreting CTG traces. Mr Porter pointed out that 
there was an apparent internal inconsistency in the 
FIGO classification of decelerations in antepartum 
CTGs, as these state that the “absence of decelerations 
except for sporadic, mild decelerations of very short 
duration” is consistent with a normal fetal heart 
pattern; but “sporadic decelerations of any type unless 
severe” are part of the definition of “suspicious” fetal 
heart patterns. Thus in cases such as this, where 
decelerations are difficult to identify, it is not obvious 
whether a CTG should be classified as normal or 
“suspicious”.17 
The case was dismissed 0n the grounds that neither 
did the plaintiff prove breach of duty through care below 
what is expected – although neither did the defendant 
prove that such care was delivered.     
 
Correct CTG interpretation 
It is a sad fact that there are obstetricians in 
training, or otherwise, who cannot interpret a CTG 
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tracing correctly. A ghastly indictment of one such 
obstetrician can be found in Azzam v General Medical 
Council.  
The expert evidence, which was accepted by the 
appellant, was that if he had not made an error in the 
assessment of a cardiograph (CTG) reading, it was 
likely that the child would have been delivered 
successfully. In October 2007, a Fitness to Practise 
Panel (the panel) of the respondent General Medical 
Council (GMC) found that the appellant had not 
interpreted or recognised signs of fetal distress as shown 
by the CTG trace…. The panel's conclusion was that the 
appellant's assessment of the CTG scan had been 
inappropriate, inadequate and irresponsible, not in the 
best interests of the mother and below the standards 
which could reasonably have been expected of a 
competent obstetrician.18 
Again, the defendant in Simms v Birmingham 
Health Authority, may have opted for euphemistic 
language but he had botched up his management with 
disastrous results:  
  “With hindsight I consider it showed some reduced 
variability and was thus abnormal. This reduced 
variability warrants continued observation but it does 
not warrant Caesarean section, unless other significant 
abnormalities develop.”19 
We speak of a serious and significant problem. In a 
series of 3600 deliveries at the Middlesex Northwick 
Park Hospital (UK) between 1996 and 2000, 22% of the 
management care problems were directly attributed to 
CTG misinterpretation.20 More than 1 in 5 of serious 
mismanagements resulting from CTG misinterpretation 
in this serious were preventable. This preventability is 
stressed by Hove et al.,21 who showed that all hypoxic 
brain injuries are potentially avoidable using established 
obstetric practice to avoid CTG misinterpretation - this 
in turn demands adequate CTG education and training. 
Such CTG misinterpretation with resultant fetal 
hypoxemia and/or academia (“birth asphyxia”) in the 
unborn (the term ‘fetal distress’ has been lately reviewed 
with dislike by the American College of Obstetricians 
and Gynaecologists is still used and accepted by others, 
such as the Royal College of Obstetricians and 
Gynaecologists of London,) comes at a massive cost. In 
2011 “birth asphyxia” comprised 50% of the UK NHS 
litigation costs,22 and in the 2000-2010 decade, the same 
NHS forked out £3.1 billion for maternity medico-legal 
claims (the highest of any speciality) mostly involving 
cerebral palsy and CTG misinterpretation.23 
The UK’s National Health Service Litigation 
Authority’s (NHSLA) emphasises that there is still need 
for improvement in general CTG education and has 
made formal attendance at CTG courses as a mandatory 
requirement to receive Clinical Negligence Scheme for 
Trusts (CNST) discounts.24 
The interpretation of a baby’s heart rate tracings 
requires special knowledge and experience. Quite often 
subtle changes in the CTG as early warning signs of 
asphyxia can only be interpreted by experienced doctors 
and junior doctors need to be supported and educated to 
acquire this skill. It is therefore crucial to have 
experienced obstetricians (consultants) working in 
labour ward during the out-of-hours period.25 
Numerous reports have repeatedly recommend 
regular in-service education programmes, as part of the 
cure of the problem. Though all experts on whichever 
side should state the truth according to their conscience, 
IPEFM may allow a wider swing of opinion due to its 
inter-observer variance – one of the difficulties of the 
subject. 
 
The Truth and nothing but…and on anticipating the 
unexpected. 
All scientific Court statements ought to be assumed 
to come under the scrutiny of ‘opposing’ experts. 
Though all experts on whichever side should state the 
truth according to their conscience, IPEFM may allow a 
wider swing of opinion due to its inter-observer variance 
– one of the difficulties of the subject.  This applies to 
obstetric defendant as well as Court appointed obstetric 
expert. One must avoid the fatal ‘faut pas’ of imagining 
that one is talking down to laymen just because there is 
no visible expert on site. In Smith v West Yorkshire 
Health Authority, Judge Silber J speaks with impressive 
authority when he demolishes an expert opinion on the 
fetal baseline heart-rate of an intrapartum CTG :  
The fallacy of Mr Hare's contention is that he 
apparently regards the peaks as being the baseline. A 
much more realistic approach is that adopted by Mr 
Mackenzie of submitting that the baseline is 130 bpm, 
which is close to a little below the rate to which the fetal 
heart rate returned on a substantial number of occasions 
during the period in question and that rate also takes 
into account the peaks and the troughs of the FHR 
during that period. My reading of the trace is that the 
baseline would have been a little higher than Mr 
Mackenzie's figure and would in the 130-140 bpm 
region, but it certainly was not 160 bpm. As I will 
explain later when I turn to the causation issue in paras 
227-230, I consider that Mr Mackenzie's estimates of the 
baseline are much more accurate than those of Mr Hare. 
Any opinion, even if expressed before a case 
reaches Court, may come back to haunt. In Gossland v 
East of England Strategic Health Authority : 
Mr Johnson agreed in cross-examination that he 
had been “putting it too high” when stating in his 
written report that before his delivery Omar showed all 
the features of a seriously sick baby; and he agreed that 
by some standards, including Beard and Finnegan's 
Foetal Heart Patterns and their Interpretation, 1974 at 
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28, Omar did not present a complicated tachycardia. He 
agreed that when describing the foetal heart beat as 
“severely abnormal” at 21.40 he was using 
“hyperbole”.26 
Hyperbole on one side and a doctor’s career on the 
other! Furthermore, the same “expert” obstetrician 
provides us with yet another rich lesson: 
… he had not anticipated that the Defendant would 
contest the case.26 
In other words this expert is saying that he feels 
free with his opinion but once in Court he would execute 
better circumspection. 
Furthermore the truth of the facts must be recorded 
legibly in the case file  not omitting date, and time. A 
Court statement such as the following is a terrible 
indictment of carelessness: 
On being recalled on 30 October, she accepted that 
it (the CTG tracing strip) should definitely have been 
dated and timed.27 
 
Ensuring interpretability of CTG strip tracing. 
It is crucial that CTG documentation should be of 
adequate quality for visual interpretation.28 
Producing “miles” of  por quality CTG strip tracing 
reflects either a persistent lack of interest in the patient  
or, equally condemning, long periods of absence from 
the bedside.  
An example of this is clearly found in Popple v 
Birmingham Women's NHS Foundation Trust (2011) 
When the judge came to deal with this, which he did in 
sub-paragraph (d) of paragraph 63 of his judgment 
(page 54), he said that he was quite satisfied that CTG 
does not reliably exclude a foetal bradycardia. He went 
on to repeat the view of the claimant's experts in their 
supplementary joint memorandum that all the obstetric 
experts have emphasised extreme difficulty in reliably 
interpreting the CTG traces due to poor quality and the 
obstetric experts in their meeting record that the CTG is 
uninterpretable from 14.21 onwards.29 
 
To Sample or NOT to sample 
Fetal blood sampling has been relegated to second 
division for so long and in so many units that the 
question seems to have now jumped from “is this CTG 
amanifestation of true fetal distress?” to “Should I 
section on this tracing or not?” This is both 
understandable as well as puzzling to those of us, mature 
enough to remember crouching on our knees in labour 
ward, struggling to obtain a fetal blood sample  through 
amnioscopes – only to repeat the procedure within the 
hour. This by-passing of FBS seems NOT to have 
penetrated Court mentality: 
In particular, it was submitted to the Lord Ordinary 
on behalf of the pursuer that at any of four points in the 
course of the labour on 1 October 1999, namely at 0810 
hrs, 1230 hrs, 1345 hrs and 1600 hrs approximately, the 
CTG trace showed features which no competent 
obstetrician exercising reasonable care would have 
interpreted otherwise than as requiring the taking of a 
foetal blood sample, which failing, the carrying out of a 
caesarean section.30 
This Court statement come in 2013 and it still 
equates fetal blod sampling with a “competent 
obstetrician”.  The purpose of sampling (a fetal blood 
sample is obtained from the scalp using a small bladed 
long handled knife passed through an amnioscope 
manoeuvred through the maternal cervix) is to measure 
the fetal pH, in stuations where IPEFM is abnormal and 
may be indicative of hypoxia. Besides the preponderance 
of habit veering to non performance of sampling in 
deference to a Caesarean Section, one needs to add the 
fact that  existing evidence disproves intrapartum FBS as 
a gold standard of proving or excluding fetal hypoxia 
(Mahendru et al. 2011).31 Incidentally the same authors 
further discount scalp lactate, pulse oximetry, fetal ECG 
waveform analysis, and central haemodynamics in 
labouring rhesus monkeys as providing such a gold 
standard.31 Neither is omission of FBS likely to be 
challenged medico-legally in cases where with a fine 
neonatal outcome after a caesarean section. However 
this excludes the exceptionally litiginous patient 
challenging the omission as part of the grounds for a 
claim of an unnecessary caesarean or a caesarean section 
were severe complications supervene.  Such a potential 
medico-legal scenario is similar  to performing intra-
partum EFM in a case where such monitoring is not 
formally indicated by most guidelines.  As far back as 
2008, Wiberg-Itzel et al.,32 found no significant 
differences in rate of acidaemia at birth after the use of 
lactate analysis or pH analysis of fetal scalp blood 
samples (pH≥ 7.25 being considered normal, 7.21–7.24 
as borderline and ≤ 7.20 as abnormal.) However, when 
all is said and done, in the section on determining 
hypoxia during labour, the NICE guidelines33 still advise 
FBS (evidence level 1b) in the presence of a 
pathological FHR trace unless there is clear evidence of 
fetal compromise, such as a prolonged deceleration 
exceeding three minutes. In fact, the same guidelines 
recommend repeating the sampling after 1 hour if the 
result is normal but the FHR tracing remains 
pathological. Although little has been published as yet 
on the actual use of guidelines in litigation,34 as matters 
stand, present Court opinion tends to be based on 
witness testimony in court regarding what is done rather 
than what ought to be done.35 Non adherence to clinical 
guidelines does not automatically imply an adverse 
outcome for the defendant,36 although the legal 
importance of guidelines is bound to increase.36 In 
Ludwig (by her mother & litigation friend Della Louise 
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Ludwig) v Oxford Radcliffe Hospitals NHS Trust and 
another  we find direct reference to the NICE guidelines: 
 
The guidelines continue as follows:  
“In cases where the CTG falls into the suspicious 
category, conservative measures should be used. In 
cases where the CTG falls into the pathological 
category, conservative measures should be used and 
fetal blood sampling be undertaken where 
appropriate/feasible. In situations where fetal blood 
sampling is not possible or appropriate then delivery 
should be expedited”.37 
Hence the answer to this section’s title is likely to 
be “not”, but in reality, medico-legally, one is traversing 
no man’s land. This is likely to hold until a clear fool 
proof formula comes to the fore by which fetal distress 
is diagnosed, for example by a computerised programme 
evaluating CTG, ST analysis of the fetal ECG…    
 
Spoliation of Evidence 
In any Court case centring on damage from intra-
partum asphyxia, the physical availability of the original 
CTG strip is of inestimable importance. If this goes 
missing ( not a rare occurrence)– this is a form of what 
is termed spoliation of evidence. This is serious business 
indeed, because however scientifically challengeable, 
the Court tends to hold that: 
the fetal monitoring strips would give fairly 
conclusive evidence as to the presence or absence of 
fetal distress, and their loss deprives the plaintiff of the 
means of proving her medical malpractice claim against 
the Hospital.38 
No Court is likely to take the situation lightly. 
Comments at Court such as 
“the fetal heart tracing has been missing since 
delivery,”39 
do not wash down well with Judge or Jury.  In  
Martelly v. New York City Health & Hosp. Corp.,40 
where the CTG tracing was missing, the Court gave the 
jury instruction to draw the strongest adverse inference 
against the defendant hospital which had a legal 
obligation both to safeguard the CTG strip as well as 
give a reasonable explanation for its disappearance.  
Some hospitals legally bind the relevant personnel 
to preserve such tracings as an intrinsic part of the 
medical record. One such example comes from New 
York Hospital41 where CTG strips must be safely 
preserved for whichever period is the longest, namely: 
6 years from the date of patient discharge from 
hospital. 
3 years after the child reached the age of maturity 
(18 years). 
6 years after the child’s death. 
The Maltese Health system will eventually have to 
evaluate this point, either pro-actively or a result of 
bitter experience. When paper based systems are used,  
the original paper strip must still be preserved even if a 
photocopy or microfilm of it exists42 and furthermore 
any photocopying must be in toto (special photocopiers 
must be used and if not available are available at 
newspaper printers) and not in separate segments. Where 
computerized clinical information systems (CIS) is in 
operation, various regulations apply in conjunction with 
advice from respective organisations or Colleges.43 
  
Conclusion   
Most Court cases centred around IPEFM are often 
both complex and contentious  by nature of the subject . 
The subjective nature of CTG interpretation as well as 
the end scope of such subjectivity in a Courtroom  are 
further challenging factors. As is standard in medico-
legal litigation  the plaintiff must establish that (a) There 
was a breach of duty by the defendant who  delivered 
care below a reasonably expected standard and (b) It was 
this  substandard care that led to the unsatisfactory final 
clinical result for which legal redress is being sought. It 
is not sufficient to prove substandard care but one must 
go the next step and show that this contributed to the 
damage in question.44 With Courtroom CTG cases it is 
often (but not invariably) the second proviso which may 
elicit the greatest difficulty, the mechanics of which are 
beyond the scope of this paper.   
There are many relevant aspects not addressed in 
this short article. However the final emphasis should be 
and is on the competency of interpretation of the 
CTGtracing.  The UK’s National Health Service 
Litigation Authority’s (NHSLA) emphasises that there is 
still need for improvement in general CTG education 
and has made formal attendance at CTG courses as a 
mandatory requirement to receive Clinical Negligence 
Scheme for Trusts (CNST) discounts.34 
The interpretation of a baby’s heart rate tracings 
requires special knowledge and experience. Quite often 
subtle changes in the CTG as early warning signs of 
asphyxia can only be interpreted by experienced doctors 
and junior doctors need to be supported and educated to 
acquire this skill. It is therefore crucial to have 
experienced obstetricians (consultants) working in 
labour ward during the out-of-hours period.45 
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